Local Institution - 0134

Chongqing, CQ 400030

0 studies enrolling now · 1 studies all time

What they study most

Colorectal Neoplasms

Studies at this site

• A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer — Stopped early